S
PFE icon

Sunpointe’s Pfizer PFE Stock Holding History

Sunpointe’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Sell
38,069
-15,750
-29% -$412K 0.26% 91
2026
Q1 		$1.51M Sell
53,819
-12,739
-19% -$339K 0.5% 45
2025
Q4 		$1.66M Buy
66,558
+2,513
+4% +$63.4K 0.55% 41
2025
Q3 		$1.63M Buy
64,045
+9,881
+18% +$244K 0.59% 40
2025
Q2 		$1.31M Buy
54,164
+44,916
+486% +$1.05M 0.52% 46
2025
Q1 		$234K Buy
9,248
+1,001
+12% +$26.2K 0.12% 155
2024
Q4 		$219K Buy
8,247
+215
+3% +$5.83K 0.11% 168
2024
Q3 		$232K Sell
8,032
-138
-2% -$4.03K 0.19% 140
2024
Q2 		$229K Sell
8,170
-2,566
-24% -$70.6K 0.15% 130
2024
Q1 		$298K Sell
10,736
-2,358
-18% -$65.4K 0.33% 93
2023
Q4 		$377K Buy
+13,094
New +$396K 0.48% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sunpointe's PFE Position: Q2 2026 in Review

Sunpointe reduced its Pfizer (PFE) stake by 29% in Q2 2026, selling an estimated $412K and leaving 38,069 shares worth $917K. The position accounts for 0.26% of the portfolio, ranked #91.

Sunpointe first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.66M in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sunpointe held 38,069 shares of Pfizer worth $917K as of Q2 2026.
  • Sunpointe sold 15,750 Pfizer shares in Q2 2026, an estimated $412K.
  • Pfizer made up 0.26% of Sunpointe's portfolio in Q2 2026, its #91 holding.
  • Sunpointe first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Sunpointe's Pfizer position peaked at $1.66M in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.